Stool Sampling in the Acute Isolated Patient , Efficient Acquiring With a Novel Device

Stool Sampling in the Acute Isolated Patient, Efficient Acquiring With a Novel Device

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06495775

Enrollment

Registered

2024-07-11

Start date

2021-11-26

Completion date

2025-12-09

Last updated

2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feasibility Study

Brief summary

stool sample device tested on patients admitted to oncological dept. with diarrhea, in order to shorten time in isolation and time to relevant treatment.

Detailed description

the stool sample device will be tested on all patients admitted to an oncological dept. on Zealand University Hospital, with diarrhea, in order to examine if the the device is feasabel and able to shorten time in isolation and time to relevant treatment.

Interventions

DEVICEquickfact

fecal sampling

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Understanding Danish * admitted to dept og oncology with diarrhea * cognitive intact * Co operable to fecal sampling

Exclusion criteria

* expected survival less than 2 weeks

Design outcomes

Primary

Measure	Time frame	Description
Number of Participants With Stool Sample Acquired	the sample is intended to be collected in an expected time range is within 1-2 hours after admission	instant acquiring of stool sample from acute admitted patients with diarrhea, the stool sample is collected bedside, and there after analysed with standard analysis for infectious pathogenes.
Safety of Device	5 minutes	sampling with out harm to patient

Countries

Denmark

Contacts

PRINCIPAL_INVESTIGATORAnne-Dorte b Krapper

Oncological department, Zealand University Hospital

Participant flow

Recruitment details

all 50 participants was recruited succes fully and in rolled in the study

Baseline characteristics

Characteristic	—
Age, Categorical <=18 years	0 Participants
Age, Categorical >=65 years	37 Participants
Age, Categorical Between 18 and 65 years	13 Participants
Number of Participants With Stool Sample Acquired and Analyzed	46 Number of Participants With Stool Sample
Region of Enrollment Denmark	50 Participants
Sex: Female, Male Female	26 Participants
Sex: Female, Male Male	24 Participants

Adverse events

Event type	EG000 affected / at risk
deaths Total, all-cause mortality	0 / 50
other Total, other adverse events	0 / 50
serious Total, serious adverse events	0 / 50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026